Advertisement

Topics

Accriva Diagnostics Company Profile

02:32 EDT 19th June 2018 | BioPortfolio

Accriva Diagnostics is the result of ITC’s 2013 acquisition of Accumetrics. The combined strengths in coagulation monitoring (ITC) and platelet testing (Accumetrics) have created a leading point-of-care diagnostic company. The Accriva portfolio of products represent over 40 years of leadership and expertise in hemostasis management, including the development, manufacturing and marketing of Hemochron®, InRhythm™ and ProTime® Microcoagulation systems; the VerifyNow® system for assessment of platelet reactivity; IRMA TruPoint® Blood Gas and Electrolyte systems; Avoximeter®CO-Oximetry systems; Tenderfoot®, Tenderlett® and Surgicutt® skin incision products. Accriva is a portfolio company of Warburg Pincus, a global private equity firm focused on growth investing.


News Articles [350 Associated News Articles listed on BioPortfolio]

Emosis, 5─Diagnostics ink exclusive distribution deal for Emo─test, HIT Confirm, in CE Mark─regulated countries

Emosis, a medical device company specialising in cytomolecular diagnostics of hemostasis disorders, and 5─Diagnostics (5─D), a worldwide distributor for haemostasis products and in─vitro diagnos...

Carbapenemase Diagnostics Market 20172022: Test Volume and Sales Forecasts by CountryUS, Europe, Japan [Report Updated: 15012018] Prices from USD $950

This report presents test volumes and sale forecasts for the US, Europe France, Germany, Italy, Spain, UK and Japan. List of TablesFrance Carbapenemase Test Volume and Diagnostics Sales ForecastGerma...

BNP Test Volume and Sales Forecasts 20172022: US, Europe, Japan [Report Updated: 15012018] Prices from USD $750

This new report from VPGMarketResearch provides analysis of BNP testing, including test volume and sales forecasts by country. Geographic CoverageFrance, Germany, Italy, Japan, Spain, UK, USAList of T...

DOD taps Ortho Clinical Diagnostics for $9.8M surgical products contract

In-vitro diagnostics company Ortho Clinical Diagnostics was awarded a contract worth up to approximately $9.8 million from th -More- 

Quotidian Technical Highlights on Selected Medical Equipment Stocks -- GenMark Diagnostics, ...

www.wallstequities.com/registration GenMark Diagnostics Carlsbad, Californiaheadquartered GenMark Diagnostics Inc.'s shares recorded a trading volume of 333,899 shares last Friday. The stock finis...

More Bad Legal News for Athena Diagnostics: Don’t Mess with Mayo

We have been reporting for more than a year about the case of Williams v. Quest Diagnostics (the parent company of Athena Diagnostics), in which the plaintiff has sued Athena and Quest for causing the...

MIP Diagnostics secures £1.5m investment for synthetic antibodies

Life sciences company MIP Diagnostics has closed a Series A financing round, in which it raised £1.5 million for its...Read More... The post MIP Diagnostics secures £1.5m investment for synthetic an...

hsCRP Test Volume and Sales Forecasts 20172022: US, Europe, Japan [Report Updated: 15012018] Prices from USD $750

This new report from VPGMarketResearch provides analysis of hsCRP testing, including test volume and sales forecasts by country. Geographic CoverageFrance, Germany, Italy, Japan, Spain, UK, USAList of...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [194 Associated PubMed Articles listed on BioPortfolio]

Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

The importance of medical imaging in the diagnosis and monitoring of cancer cannot be overstated. As personalized cancer treatments are gaining popularity, a need for more advanced imaging techniques ...

A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.

To assess a new and highly specific, but low-cost, easily performed and suitable for large-scale applications method for renal fibrosis (RF) diagnostics.

Nucleic acid diagnostic approaches in parasitology.

Nucleic acid diagnostic technologies are partly replacing traditional microscopy and antigen detection methods in parasitological diagnostics. In particular, the diagnostics of parasitic diarrhea is u...

Is bronchoscopy always justified in diagnosis of haemoptysis?

Fiber-optic bronchoscopy (FOB) is commonly performed in the first line in diagnostic process of haemoptysis. However, lots of evidences suggest that in haemoptysis FOB do not always provide additional...

Molecular allergy diagnostics refines characterization of children sensitized to dog dander.

Sensitization to dog dander is an important risk factor for rhino-conjunctivitis and asthma, but not sufficient for diagnosing dog allergy. Molecular allergy diagnostics offers new opportunities for r...

Clinical Trials [197 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Companies [920 Associated Companies listed on BioPortfolio]

Accriva Diagnostics

Accriva Diagnostics is the result of ITC’s 2013 acquisition of Accumetrics. The combined strengths in coagulation monitoring (ITC) and platelet testing (Accumetrics) have cre...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs...

More Information about "Accriva Diagnostics" on BioPortfolio

We have published hundreds of Accriva Diagnostics news stories on BioPortfolio along with dozens of Accriva Diagnostics Clinical Trials and PubMed Articles about Accriva Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accriva Diagnostics Companies in our database. You can also find out about relevant Accriva Diagnostics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record